Euroapi (EAPI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting opened with gratitude to shareholders, acknowledgment of challenging market conditions, and a focus on transparency and engagement.
Agenda included 22 ordinary and 3 extraordinary resolutions, covering financial statements, director renewals, compensation, and strategic plans.
Roadshows and governance updates were presented, with Emmanuel Blin as Chair of the Board and Elizabeth Bastoni as Chair of the Remuneration & Nominations Committee.
Statutory auditors from Ernst & Young and BDO Paris present to review reports.
Financial performance review
2025 revenues were EUR 848 million, down 7% from 2024.
Core EBITDA (excluding one-offs) was EUR 66.2 million (7.8% margin); reported EBITDA EUR 9.9 million after EUR 56.3 million in non-recurring items.
Net loss increased to EUR 211 million from EUR 130 million in 2024, mainly due to impairments and restructuring.
Capital expenditures totaled EUR 77 million (9% of revenues), with 55% for growth and performance projects.
Board reviewed consolidated financial statements and results for H1 2025 and FY 2025, and evaluated the 2026 budget and group risks.
Board and executive committee updates
Appointment of a new CEO in late 2024 and near-total renewal of the Executive Committee to drive transformation.
Appointment of Tristan Imbert as Independent Director.
Board at end of 2025: 63% independents, 40% women, 4 nationalities, 2 employee representatives.
Board composition now more focused, with increased independence and international representation.
Nine board meetings held in 2025 with almost 100% participation; committees restructured for greater effectiveness.
Latest events from Euroapi
- Core EBITDA margin rose to 7.8% in 2025 despite a 7% sales decline and ongoing net losses.EAPI
H2 202529 Apr 2026 - Transformation targets €75–80M incremental EBITDA by 2027, with €200M hybrid bond support.EAPI
Investor Update3 Feb 2026 - Net sales declined 9.6% and net loss reached €34.8m, but transformation is on track.EAPI
H1 20242 Feb 2026 - Lock-up extended to 2026; 2025 sales outlook lowered, EBITDA margin target maintained.EAPI
Trading Update16 Dec 2025 - 2024 sales fell 10%, but 2025 targets margin recovery and positive cash flow.EAPI
H2 20241 Dec 2025 - All resolutions passed as new leadership and strategic plans drive recovery and governance.EAPI
AGM 202518 Nov 2025 - Net sales fell 8.2% and Core EBITDA margin was 9.6%, with improved H2 outlook and key asset divestment.EAPI
H1 202516 Nov 2025